A system for producing amino acids using plasma and blood cells separated from whole blood
Through centrifugation and hydrolytic enzyme treatment, the slaughtered blood is separated into plasma and blood cells, and the hypotonic solution is used to destroy the blood cell membrane, achieving efficient amino acid conversion, solving the problems of high cost and low efficiency in the existing technology, and promoting resource recycling and environmental protection. .
Patent Information
- Application Number
- CN202210456262.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2021-05-20
- Filing Date
- 2022-04-27
- Publication Date
- 2024-11-01
- Estimated Expiration
- 2042-04-27
AI Technical Summary
The prior art has problems of high cost, low efficiency and complex processes when using slaughtered blood to produce amino acids, making it difficult to recycle waste blood on a large scale.
The whole blood is separated into plasma and blood cells by using a centrifugal separator, and the blood cell membrane is destroyed by the combination of hydrolase and hypotonic solution, achieving efficient amino acid conversion and filtration, and using disinfectants to prevent spoilage.
It achieves efficient conversion of amino acids in a short period of time, reduces production costs, provides an efficient way to recycle resources, and promotes environmental protection and food safety.
Smart Images

Figure CN114672413B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a system for producing amino acids using plasma and blood cells separated from whole blood. Background Art
[0002] In the 21st century, the human dietary environment has been changing with the continuous increase in meat consumption. As the main sources of meat, livestock, poultry and fish have also shown an explosive growth trend in terms of species and number. Therefore, the waste blood generated during the slaughter of pigs and cattle, which are the most widely consumed, is as high as 15 million tons per year worldwide. Together with the blood of poultry and fish, the amount of waste blood is staggering. However, only 5-10% of this waste blood is recycled as raw materials for food, feed, medicines, etc., and most of it is dumped into the ocean. Since 2013, according to the London Convention for the Prevention of Marine Pollution, the international community has completely banned the injection of waste blood into the ocean. Countries not only have to bear the high cost of waste blood treatment, but also face the problem of a large amount of secondary waste generated during the treatment of waste blood, which pollutes the environment.
[0003] Slaughterhouse blood is composed of 78-79% water, about 18% protein, 0.9% fat, and 1.8% carbohydrates, minerals, and vitamins, etc. It is composed of high-quality nutrients with relatively high potential value. If cost-effective technology and processes can be developed to recycle waste blood, it can become a model for resource recycling.
[0004] The core technology of recycling slaughter blood is to decompose the high molecular organic matter (protein) that accounts for the majority of whole blood into low molecular organic matter (amino acid) with high utilization value. From the perspective of traditional technology, whole blood is simply heated and dried to produce blood powder protein, or plasma is separated from whole blood using a special centrifuge for blood, and plasma (serum) protein is produced after heating and drying, or amino acids are produced by strong acid or strong alkali decomposition. However, most traditional technologies require the purchase of expensive equipment, excessive processing costs, low quality, and a large amount of secondary waste. In addition, slaughter blood is disliked as a substance that is prone to corruption and pollution, and related research is still in a very depressed state.
[0005] The existing technologies for recycling slaughter blood include the following: Korean Patent Registration Announcement No. 10-1390516 (2014.04.23) "High-concentration amino acid components using animal waste blood and their production methods", which uses organic acid to perform pH correction and precipitation on the whole blood of slaughter waste blood once, and then uses sodium hydroxide to perform pH correction twice, and then the corrected protein is treated with enzymes and disinfected. Korean Registration Announcement No. 10-1502376 (2015.03.09) "Device for producing amino acid liquid fertilizer and protein dry feed using slaughter blood" records methods such as crushing, ultrasonic pretreatment, enzyme decomposition, solid-liquid separation, and microwave irradiation of blood cells in the whole blood of slaughter blood. It can be seen from the above-mentioned prior literature that in order to crush the blood cell membrane with the highest protein content when enzymatically decomposing slaughter blood, a very complicated manufacturing process is still required and the efficiency is also low, so large-scale recycling of waste blood still has certain limitations. Therefore, there is an urgent need for low-cost and high-efficiency technologies and processes for quickly and effectively crushing blood cells and converting slaughter blood into amino acids.
[0006] [Prior art literature]
[0007] [Patent Literature]
[0008] (Patent Document 1) Korean Patent Registration Publication No. 10-1390516 (Registration Date 2014.04.23)
[0009] (Patent Document 2) Korean Registration Publication No. 10-1502376 (registration date 2015.03.09) Summary of the invention
[0010] Technical issues
[0011] In order to solve the above-mentioned problems existing in the conventional technology, the object of the present invention is to provide a low-cost and efficient amino acid production system which can improve the amino acid conversion yield in a short time when producing amino acids using whole blood.
[0012] Technical Solution
[0013] The present invention provides an amino acid manufacturing system, comprising: a centrifuge for centrifuging whole blood of livestock, poultry and fish; a plasma hydrolysis tank for receiving plasma separated by the centrifuge and comprising a first indirect heater and a first quantitative injection device; a blood cell hydrolysis tank for receiving blood cells separated by the centrifuge and comprising a second indirect heater and a second quantitative injection device; a first filter for filtering plasma amino acids hydrolyzed in the plasma hydrolysis tank; a second filter for filtering blood cell amino acids hydrolyzed in the blood cell hydrolysis tank; and a plasma amino acid storage tank and a blood cell amino acid storage tank for respectively receiving the plasma amino acids and blood cell amino acids filtered in the first filter and the second filter, the plasma amino acid storage tank comprising a first disinfectant injection device, and the blood cell amino acid storage tank comprising a second disinfectant injection device.
[0014] In one embodiment of the present invention, the centrifuge and the plasma hydrolysis tank, the centrifuge and the blood cell hydrolysis tank, the plasma hydrolysis tank and the first filter, the blood cell hydrolysis tank and the second filter, the first filter and the plasma amino acid storage tank, and the second filter and the blood cell amino acid storage tank are connected respectively by a transport pipe.
[0015] In one embodiment of the present invention, the conveying pipe between the centrifuge and the plasma hydrolysis tank, the conveying pipe between the centrifuge and the blood cell hydrolysis tank, the conveying pipe between the plasma hydrolysis tank and the first filter, and the conveying pipe between the blood cell hydrolysis tank and the second filter can be equipped with conveying pumps respectively.
[0016] In one embodiment of the present invention, the plasma hydrolysis tank, the plasma amino acid storage tank, the blood cell hydrolysis tank, and the blood cell amino acid storage tank further include a circulation pipe for reprocessing the products discharged from the respective tanks.
[0017] In one embodiment of the present invention, one end of each of the above-mentioned circulation pipes is connected to a conveying pipe that conveys the product from each tank body to the next stage, and the other end is connected to each tank, wherein the connection portion of the above-mentioned conveying pipe and the circulation pipe is provided with: a valve to connect the conveying pipe with the circulation pipe and cut off the conveying pipe or block the connection between the conveying pipe and the circulation pipe.
[0018] In one embodiment of the present invention, the amino acid production system may further include: a hypotonic solution supply tank, which supplies the hypotonic solution through the second quantitative injection device of the blood cell hydrolysis tank.
[0019] In one embodiment of the present invention, the blood cell hydrolysis tank uses the hypotonic solution supplied from the hypotonic solution supply tank to destroy blood cell membranes by utilizing the hemolytic effect based on the osmotic pressure principle.
[0020] In one embodiment of the present invention, the amino acid production system may further include: a mixed amino acid storage tank for mixing and storing the plasma amino acids and blood cell amino acids delivered from the plasma amino acid storage tank and the blood cell amino acid storage tank.
[0021] In one embodiment of the present invention, the first disinfectant injection device and the second disinfectant injection device may add one or more food additives selected from potassium sorbate, sodium benzoate, and silicic acid as disinfectants.
[0022] In one embodiment of the present invention, the first disinfectant injection device and the second disinfectant injection device may also add one or more selected from sodium chloride (NaCl), sodium bicarbonate (NaHCO3), pyroacetic acid, pumpkin leaf hot water extract and rambutan ethanol extract as disinfectants.
[0023] Technical Effects
[0024] According to the amino acid production system of the present invention, plasma and blood cells are separated from whole blood and used, and the blood cell membrane is destroyed by hemolysis, so that the conversion yield of amino acids can be increased in a short time, and amino acids can be produced efficiently at low cost.
[0025] Furthermore, the amino acid manufacturing system of the present invention can be used to recycle slaughter blood with high potential value, thereby providing positive effects such as increasing food production, ensuring food safety, improving soil, and protecting the environment. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 This is a diagram showing the overall structure of a system for separating whole blood into plasma and blood cells to produce amino acids according to an embodiment of the present invention.
[0027] Figure 2 This is a cross-sectional view of the entire system for separating whole blood into plasma and blood cells to produce amino acids according to one embodiment of the present invention.
[0028] Figure 3 To enlarge Figure 2 Schematic diagram of the parts of the centrifuge used in separating plasma and blood cells.
[0029] Figure 4 To enlarge Figure 2 A cross-sectional view of a portion of a first quantitative injection device used in the method for quantitatively supplying a pH correction solution and a hydrolase to a plasma hydrolysis tank.
[0030] Figure 5 To enlarge Figure 2 A cross-sectional view of a second quantitative injection device used in the method for quantitatively supplying a hypotonic solution, a pH correction solution, and a hydrolase to a blood cell hydrolysis tank.
[0031] Description of reference numerals:
[0032] 10: Centrifugal separator 10-1: Driving unit (motor)
[0033] 10-2: Rotating body (Separation Bowl) 11-1: Plasma transfer pump
[0034] 11-2: Blood cell delivery pump 11-3: The third delivery pump
[0035] 11-4: Fourth delivery pump 11-5: Fifth delivery pump
[0036] 11-6: Sixth delivery pump 11-7: Seventh delivery pump
[0037] 12: Plasma hydrolysis tank 12-1: First indirect heater
[0038] 12-2: First mixer 12-3: First drive motor
[0039] 13: Blood cell hydrolysis tank 13-1: Second indirect heater
[0040] 13-2: Second mixer 13-3: Second drive motor
[0041] 14: Plasma amino acid storage tank 14-1: The third mixer
[0042] 14-2: The third drive motor 15: Blood cell amino acid storage tank
[0043] 15-1: The fourth mixer 15-2: The fourth drive motor
[0044] 16: Plasma + blood cell mixed amino acid storage tank
[0045] 16-1: Fifth mixer 16-2: Fifth drive motor
[0046] 17: First filter 17-1: Second filter
[0047] 18: First quantitative injection device 19: Second quantitative injection device
[0048] 20: First disinfectant injection device 21: Second disinfectant injection device
[0049] 22: Inlet 23: Discharge port
[0050] 24: Circulation pipe 25: Check valve DETAILED DESCRIPTION
[0051] The present invention is described in detail below.
[0052] The present invention relates to an amino acid manufacturing system for separating high molecular organic whole blood into plasma and blood cells to manufacture low molecular organic amino acids.
[0053] For the amino acid production method using the above amino acid production system, first, the whole blood of livestock, poultry, fish, etc. produced at the slaughter site is separated into plasma and blood cells using a centrifuge. The plasma transported to the plasma hydrolysis tank is heated to a temperature suitable for the activity of the hydrolase, and after the pH is corrected, the plasma hydrolase is injected for hydrolysis to obtain high-quality plasma amino acids. A hypotonic solution is appropriately added to the blood cells transported to the blood cell hydrolysis tank, and the blood cell membrane that hinders the activity of the hydrolase is destroyed by the hemolysis (hemolysis) based on the osmotic pressure principle, and then heated to a temperature suitable for the activity of the hydrolase, and after the pH is corrected, the blood cell hydrolase is injected for hydrolysis to obtain high-quality blood cell amino acids. In addition, the plasma amino acids and blood cell amino acids that have passed through the filter to remove foreign matter are sterilized and stored (used) or mixed and stored when necessary to prevent corruption and deterioration.
[0054] The whole blood of the slaughtered blood is roughly divided into plasma and blood cells. The liquid component plasma is composed of albumin, globulin, fibrinogen, etc., and the cell component blood cells are composed of red blood cells, white blood cells, blood platelets, etc. The specific components are shown in Table 1 below.
[0055]
Table 1
[0056]
[0057] like Figure 2 As shown, the amino acid production system of the present invention comprises:
[0058] A centrifuge 10 is used to centrifuge the whole blood of livestock, poultry and fish;
[0059] The plasma hydrolysis tank 12 receives the plasma separated from the centrifuge and includes a first indirect heater 12-1 and a first quantitative injection device 18;
[0060] The blood cell hydrolysis tank 13 receives the blood cells separated from the centrifuge and includes a second indirect heater 13-1 and a second quantitative injection device 19;
[0061] A first filter 17 is used to filter the plasma amino acids hydrolyzed in the plasma hydrolysis tank 12;
[0062] The second filter 17-1 filters the blood cell amino acids hydrolyzed in the blood cell hydrolysis tank 13; and
[0063] The plasma amino acid storage tank 14 and the blood cell amino acid storage tank 15 respectively receive the plasma amino acids and blood cell amino acids filtered from the first filter and the second filter. The plasma amino acid storage tank 14 includes a first disinfectant injection device 20, and the blood cell amino acid storage tank 15 includes a second disinfectant injection device 21.
[0064] In one embodiment of the present invention, the following structures can be connected by conveying pipes respectively: the centrifuge 10 and the plasma hydrolysis tank 12; the centrifuge 10 and the blood cell hydrolysis tank 13; the plasma hydrolysis tank 12 and the first filter 17; the blood cell hydrolysis tank 13 and the second filter 17-1; the first filter 17 and the plasma amino acid storage tank 14; the second filter 17-1 and the blood cell amino acid storage tank 15.
[0065] In one embodiment of the present invention, delivery pumps may be provided at the following positions: a delivery pipe between the centrifuge 10 and the plasma hydrolysis tank 12; a delivery pipe between the centrifuge 10 and the blood cell hydrolysis tank 13; a delivery pipe between the plasma hydrolysis tank 2 and the first filter 17; and a delivery pipe between the blood cell hydrolysis tank 13 and the second filter 17-1.
[0066] In one embodiment of the present invention, the plasma hydrolysis tank 12, plasma amino acid storage tank 14, blood cell hydrolysis tank 13, and blood cell amino acid storage tank 15 may also include a circulation pipe 24 to return the products discharged from each tank body to the original tank body for reprocessing.
[0067] In one embodiment of the present invention, one end of each of the above-mentioned circulation pipes 24 is connected to a conveying pipe that conveys the product from each tank body to the next stage, and the other end is connected to each tank body, wherein the connection portion of the above-mentioned conveying pipe and the circulation pipe is provided with: a valve to connect the conveying pipe with the circulation pipe and cut off the conveying pipe or block the connection between the conveying pipe and the circulation pipe.
[0068] In one embodiment of the present invention, a hypotonic solution supply tank for supplying a hypotonic solution through a second quantitative injection device 19 of the blood cell hydrolysis tank 13 may be further included.
[0069] In a specific embodiment of the present invention, the blood cell hydrolysis tank 13 can play the following role: the hypotonic solution supplied by the hypotonic solution supply tank destroys the blood cell membrane by utilizing the hemolytic effect based on the osmotic pressure principle.
[0070] In one embodiment of the present invention, a mixed amino acid storage tank 16 for mixing and storing the plasma amino acids and blood cell amino acids delivered from the plasma amino acid storage tank 14 and the blood cell amino acid storage tank 15 may be further included.
[0071] In one embodiment of the present invention, the first disinfectant injection device 20 and the second disinfectant injection device 21 may add one or more food additives selected from potassium sorbate, sodium benzoate, and silicic acid as disinfectants.
[0072] In one embodiment of the present invention, the first disinfectant injection device and the second disinfectant injection device may also add one or more selected from sodium chloride (NaCl), sodium bicarbonate (NaHCO3), pyroacetic acid, pumpkin leaf hot water extract and rambutan ethanol extract as disinfectants.
[0073] The centrifuge 10 is a device utilizing centrifugal force. If whole blood from slaughtered animals is injected and the motor is driven to rotate at high speed, the whole blood can be separated into plasma and blood cells due to the difference in specific gravity. Preferably, a continuous centrifuge capable of separating plasma and blood cells in large quantities is used for industrial production.
[0074] Furthermore, the pH calibration solution injected into the plasma hydrolysis tank 12 and the blood cell hydrolysis tank 13 by the first quantitative injection device 18 and the second quantitative injection device 19 is a solution that calibrates the pH value of plasma and blood cells from 7.2 to 7.3 to a pH value range of 4.5 to 10.5 (preferably, calibrated to a pH value range of 5.5 to 9.5) that is most suitable for the activity of different types of hydrolytic enzymes. Citric acid (C6H8O7), acetic acid (C2H4O2), etc. can be representatively used as calibration solutions for acidification, and sodium hydroxide (NaOH), potassium hydroxide (KOH), etc. can be representatively used for alkalization.
[0075] The hypotonic solution (hypotonic) injected into the blood cell hydrolysis tank by the above-mentioned second quantitative injection device 19 is a general term for solutions with a dissolving concentration lower than that of blood cells. Its purpose is to destroy the blood cell membrane that is the cause of hindering the activity of hydrolytic enzymes through the hemolysis (hemolysis) effect of the osmotic pressure principle. Representatively, distilled water, tap water, etc. with a concentration lower than 0.9% of the blood cell fluid can be used. The amount of hypotonic solution used to destroy the cell membrane can be 50-300% v / v (based on distilled water) based on 100% v / v of blood cells, and is preferably 80-250% v / v.
[0076] The first disinfectant injection device 20 and the second disinfectant injection device 21 are used to inject disinfectants. The disinfectant is used to prevent the hydrolyzed plasma amino acids and blood cell amino acids from being spoiled and deteriorating and to ensure the quality. One or more selected from potassium sorbate, sodium benzoate, silicic acid, etc. as food additives can be used. The disinfectant can be 0.01-0.45% w / v, preferably 0.05-0.35% w / v.
[0077] Furthermore, according to the uses and functions of plasma amino acids and blood cell amino acids, sodium chloride (NaCl), sodium bicarbonate (NaHCO3), wood acetic acid, etc. can be used, and the use range can include the following range: sodium chloride (NaCl) contains 5-30% w / v (preferably 10-20% w / v); sodium bicarbonate (NaHCO3) contains 0.5-5% w / v (preferably 1-4% w / v); wood acetic acid contains 10-60% v / v (preferably 15-40% v / v), among which they can also be mixed in a certain proportion as needed.
[0078] The amino acid production system of the present invention can produce amino acids in the following manner.
[0079] Provided is a manufacturing method comprising the following steps:
[0080] a) Centrifuging whole blood from livestock, poultry and fish to separate it into plasma and blood cells;
[0081] b) transporting the separated plasma to a plasma hydrolysis tank, adjusting the temperature of the plasma to 45-65°C, adjusting the pH value to 4.5-10.5, injecting plasma hydrolase to hydrolyze the high molecular organic plasma into low molecular organic plasma amino acids;
[0082] c) transporting the separated blood cells to a blood cell hydrolysis tank, injecting a hypotonic solution to destroy the blood cell membrane through hemolysis based on the osmotic pressure principle, adjusting the temperature of the blood cells with destroyed cell membranes to 45-65° C., and adjusting the pH value to 4.5-10.5, injecting blood cell hydrolase to hydrolyze the high molecular weight organic blood cells into low molecular weight organic blood cell amino acids;
[0083] d) filtering the hydrolyzed plasma amino acids and blood cell amino acids respectively to remove foreign matter;
[0084] e) transporting the filtered plasma amino acids and blood cell amino acids to a plasma amino acid storage tank and a blood cell amino acid storage tank respectively; and
[0085] f) injecting disinfectant into the plasma amino acid storage tank and the blood cell amino acid storage tank respectively.
[0086] The plasma hydrolase and blood cell hydrolase mentioned above may each include at least one selected from lipolytic enzymes, polysaccharide degrading enzymes, and fibrinolytic enzymes.
[0087] The pH correction in the above-mentioned plasma hydrolysis tank and blood cell hydrolysis tank can use one or more selected from citric acid (C6H8O7) and acetic acid (C2H4O2) in acid correction, and can use one or more selected from sodium hydroxide (NaOH) and potassium hydroxide (KOH) in alkaline correction.
[0088] The disinfectant injected into the above-mentioned plasma amino acid storage tank and blood cell amino acid storage tank can be one or more selected from sodium chloride (NaCl), sodium bicarbonate (NaHCO3), and wood acetic acid.
[0089] The disinfectant injected into the plasma amino acid storage tank and the blood cell amino acid storage tank may further include one or more selected from pumpkin leaf hot water extract and rambutan ethanol extract added at a concentration of 0.01-2% w / w.
[0090] The advantages of the present invention can be fully understood by referring to the specific embodiments described in the accompanying drawings. The present invention can have various specific embodiments according to the on-site conditions such as the type and scale of the organic matter, and is not limited to the specific embodiments described herein. In addition, in order to better illustrate the advantages of the present invention, the symbols or terms used to help understand the constituent elements of the specification should not be limited to the meanings in the dictionary, but should be interpreted according to the technical concepts intended in the present invention.
[0091] The present invention relates to a system for producing amino acids by separating whole blood into plasma and blood cells, Figures 1 to 5 Provide explanation.
[0092] First, in order to realize a specific embodiment of the present invention, the centrifuge 10 used in the pretreatment is used as a device for separating the components in the mixed liquid by using centrifugal force and specific gravity difference. The basic principle of separating whole blood into plasma and blood cells is that when the whole blood is rotated at high speed by the driving unit 10-1 and the rotating body 10-2, plasma (specific gravity 1.02-1.03) and blood cells (specific gravity 1.09-1.10) of different specific gravities will be separated under the action of strong centrifugal force. Preferably, the greater the specific gravity, the greater the centrifugal force, so that the plasma is separated inward and the blood cells are separated outward. In addition, the optimal rotation speed of the centrifuge for separating whole blood into plasma and blood cells is 10,000 rpm. If it exceeds 10,000 rpm, blood cell crushing will occur and the efficiency will be reduced, so it is necessary to pay attention.
[0093] In addition, the plasma hydrolysis tank 12 includes: a first indirect heater 12-1 for maintaining a reasonable temperature; a first mixer 12-2 for stirring and mixing the contents; a first quantitative injection device for quantitatively injecting a pH correction solution and a hydrolase through a first quantitative pump 18, etc., thereby forming various conditions required for hydrolyzing the plasma injected through the first delivery pump 11-1.
[0094] The blood cell hydrolysis tank 13 also includes: a second indirect heater 13-1 for maintaining a suitable temperature; a second mixer 13-2 for stirring and mixing the contents; a second quantitative injection device for quantitatively injecting a hypotonic solution, a pH correction solution and a hydrolase through a second quantitative pump 19, etc., thereby forming various conditions for hydrolyzing the blood cells injected through the second delivery pump 11-2.
[0095] Here, the first indirect heater 12-1 and the second indirect heater 13-1 are devices that can indirectly heat the contents by building heating rods into the middle layer of the triple-structured tank body. They have low heat loss and easy temperature control, and are therefore widely used as independent heat sources.
[0096] Here, the temperature, which is an important condition for the activity of the hydrolase, is set to 45 to 65° C. (preferably 50 to 60° C.), and the stirring speed of the first stirrer 12 - 2 and the second stirrer 13 - 2 is set to 60 to 360 rpm (preferably 90 to 180 rpm).
[0097] Here, the purpose of the pH calibration solution in the first quantitative injection device and the second quantitative injection device is as follows: to calibrate the pH value of plasma and blood cells in the pH range of 7.2 to 7.3 to a pH range of 4.5 to 10.5 (preferably a pH range of 5.5 to 9.5) suitable for the activity of various hydrolases, wherein citric acid (C6H8O7), acetic acid (C2H4O2), etc. are representatively used in acid calibration, and sodium hydroxide (NaOH), potassium hydroxide (KOH), etc. are representatively used in alkaline calibration. The dosage is calculated according to the pH calibration method based on the substrate specificity of the injected hydrolase, the appropriate temperature, etc.
[0098] Here, the hypotonic solution (hypotonic) delivered from the above-mentioned hypotonic solution supply tank to the second quantitative injection device is a general term for solutions with a dissolving concentration lower than that of blood cells. Its function is to destroy the blood cell membrane, which is the biggest obstacle to the activity of hydrolytic enzymes, through hemolysis. Distilled water, tap water, etc. with a concentration lower than 0.9% of the blood cell fluid concentration can be used. The amount of hypotonic solution used to destroy the cell membrane is 50-300% v / v (based on distilled water) based on 100% v / v of blood cells, preferably 80-250% v / v. Of course, using more hypotonic solution can destroy the cell membrane faster and shorten the hydrolysis time, but it will reduce the concentration and is not conducive to quality and effect.
[0099] Here, the plasma or blood cell hydrolase injected by the first quantitative injection device and the second quantitative injection device is fermented, cultured and concentrated by microorganisms, and can hydrolyze the main component protein of matrix plasma and blood cells, as well as trace residual fat, polysaccharides, cellulose, etc. Among the above-mentioned degrading enzyme components, the protease can be one or more of protex, trypsin, bromeline, papain, actinidain, flavorzyme, protamex, collagenase, esperase, liquanase, savinase, everlase, etc. The lipolytic enzyme can be one or more of Lipex, Lipopan, palatase, lecithinase, and lactozyme. The polysaccharide degrading enzyme can be one or more of stainzyme, termamyl, glucoamylase, pullulanase, etc. The cellulolytic enzyme can be one or more of carezyme, celluclean, xylanase, and cellulase, etc. The above-mentioned degrading enzymes of various components can be purchased or prepared at home, but in order to improve the hydrolysis efficiency, it is recommended to use a hydrolase prepared in a certain ratio according to the characteristics of the substrate such as temperature, pH, type (endo, exe), etc. For example, the above-mentioned hydrolase can be used at 0.1% v / v-2% v / v, preferably 0.2% v / v-0.6% v / v.
[0100] As described above, when whole blood is separated into plasma and blood cells, if various conditions such as temperature, stirring speed, pH correction and hypotonic solution suitable for hydrolase activity are provided to destroy the cell membrane, it only takes about 120 to 150 minutes to achieve an amino acid conversion rate of more than 98% after injecting hydrolase into plasma and blood cells respectively. In the case of using whole blood directly by the usual method, it takes more than 360 to 540 minutes to achieve an amino acid conversion rate of more than 90%. Compared with this, the amino acid conversion rate achieved in a short time by the present invention is an epoch-making progress.
[0101] As described above, the plasma amino acids obtained from the plasma hydrolysis tank 12 are transported to the plasma amino acid storage tank 14 through the third delivery pump 11-3 and the first filter 17 for removing residual foreign matter. The blood cell amino acids obtained from the blood cell hydrolysis tank 13 are also transported to the blood cell amino acid storage tank 15 through the fourth delivery pump 11-4 and the second filter 17-1 for removing residual foreign matter.
[0102] In addition, the plasma amino acid storage tank 14 is equipped with a third mixer 14-1 for stirring and mixing the hydrolyzed plasma amino acids and a first disinfectant injection device 20 for quantitatively injecting disinfectant through a third quantitative pump.
[0103] The blood cell amino acid storage tank 15 is also equipped with a fourth mixer 15-1 for stirring and mixing the hydrolyzed blood cell amino acids and a second disinfectant injection device 21 for quantitatively injecting disinfectant through a fourth quantitative pump.
[0104] Here, the disinfectant used by the first disinfectant injection device and the second disinfectant injection device is used to prevent the hydrolyzed plasma amino acids and blood cell amino acids from being corrupted or deteriorated, and its ingredients are one or more selected from potassium sorbate, sodium benzoate, salicylic acid, etc., which are used as food additives. The concentration used is 0.01 to 0.45% w / v, preferably 0.05 to 0.35% w / v.
[0105] Furthermore, according to the purpose and function of plasma amino acids and blood cell amino acids, one or more of sodium chloride (NaCl), sodium bicarbonate (NaHCO3), wood acetic acid, etc. can be used, and the concentration used is sodium chloride (NaCl) 5-30% w / v (preferably 10-20% w / v), sodium bicarbonate (NaHCO3) 0.5-5% w / v (preferably 1-4% w / v), wood acetic acid 10-60% v (preferably 15-40% v / v), and they can also be mixed in a suitable ratio as needed.
[0106] After the plasma amino acids or blood cell amino acids are sterilized, when a plant antibacterial extract with a concentration of 0.01-2% w / w is added, the shelf life of the amino acids can be extended. The plant antibacterial extract can be one or more of pumpkin leaf hot water extract and rambutan ethanol extract. In particular, when mixed in a weight ratio of 3:7 to 7:3, the antibacterial function will be better.
[0107] Pumpkin leaves are rich in dietary fiber and vitamins, low in calories, and help to reduce fat and beautify the skin. They contain beta-carotene, which can prevent cancer, lutein, which can relieve eye fatigue, and potassium, which can purify blood vessels and lower cholesterol.
[0108] In addition, it has antioxidant effects, which can not only prevent aging and adult diseases, but also help relieve fatigue and oral health, and help relieve cold hands and feet or anemia.
[0109] The inventors discovered that the pumpkin leaf hot water extract has antibacterial activity during their research on the efficacy of the pumpkin leaves, and applied the antibacterial activity to the present invention.
[0110] The rambutan mentioned above is called "Rambut" in Indonesian. It comes in red and yellow colors, with the yellow one being sweeter and tastier. Breaking the peel will reveal the transparent flesh, which is sweet.
[0111] The inventors have discovered that the rambutan ethanol extract has antibacterial activity and has applied it to the present invention.
[0112] In the present invention, the third mixer 14-1 and the fourth mixer 15-1 are used to uniformly mix the disinfectant for preservation and quality assurance and the additives added according to the purpose. The stirring speed is set to 10-60 rpm (preferably 20-50 rpm) for maturation and stabilization.
[0113] As described above, in order to prevent deterioration and maintain quality, the plasma amino acids and blood cell amino acids that have been sterilized and are in a mature and stable state can be used or stored in various storage tanks according to appropriate uses.
[0114] Furthermore, the plasma amino acid storage tank 14 and the plasma amino acids stored once are transported to the plasma-blood-cell mixed amino acid storage tank 16 through the fifth transport pump 11-5, and the blood cell amino acids stored once in the blood cell amino acid storage tank 15 are transported to the plasma-blood-cell mixed amino acid storage tank 16 through the sixth transport pump 11-6.
[0115] Here, the plasma and blood cell mixed amino acid storage tank 16 is equipped with a fifth mixer 16-1 to stir and mix the delivered plasma amino acids and blood cell amino acids, and is also equipped with a seventh delivery pump 11-7 whose injection port and discharge port are connected to the tank body for circulation. The stirring speed of the fifth mixer 16-1 is the same as that of the third mixer 14-1 and the fourth mixer 15-1, and is set to 10-60rpm (preferably 20-50rpm) for maturation and stabilization.
[0116] Here, the third to seventh delivery pumps 11-3 to 11-7 not only play a delivery function, but also play an auxiliary role in stirring and mixing the contents because the inlet and the discharge port are connected to the inside of the tank.
[0117] As described in the above-mentioned specific embodiments of the present invention, the present invention relates to a system and method for separating whole blood of livestock, poultry and fish, etc., which contains high molecular organic matter, into plasma and blood cells, and producing low molecular organic amino acids. The present invention provides a system and method for a technology and process for quickly converting high molecular organic whole blood into low molecular organic amino acids and improving its conversion yield, which comprises a stage of separating whole blood into plasma and blood cells by a blood-specific centrifuge, etc.; a stage of transporting the separated plasma and blood cells to a plasma hydrolysis tank and a blood cell hydrolysis tank respectively with hydrolysis conditions such as heating, stirring and additives; a hydrolysis stage of converting the plasma and blood cells injected into the respective tanks into amino acids by hydrolytic enzymes; a primary storage stage of the plasma amino acids and blood cell amino acids obtained after the hydrolysis is completed, after passing through a filter to remove foreign matter, and then transporting them to a plasma amino acid storage tank and a blood cell amino acid storage tank respectively, and then storing them after disinfection treatment to prevent deterioration or using them according to necessary purposes; a secondary storage stage of transporting the plasma amino acids and blood cell amino acids stored in the plasma amino acid storage tank and the blood cell amino acid storage tank once to a mixed amino acid storage tank, or using them according to purposes, which is composed of a system and method for a technology and process for a low-cost and high-efficiency structure, which comprises a stage of separating whole blood into plasma and blood cells by a blood-specific centrifuge, etc.; a stage of transporting the separated plasma and blood cells to a plasma hydrolysis tank and a blood cell amino acid storage tank respectively with hydrolysis conditions such as heating, stirring and additives; a hydrolysis stage of converting the plasma and blood cell amino acids injected into the respective tanks into amino acids by hydrolysis enzymes; a system and method for a technology and process for quickly converting high molecular organic whole blood into low molecular organic amino acids and improving its conversion yield, and a system and method for a technology and process for a low-cost and high-efficiency structure, and a system and method for a technology and process for a technology and process for a technology and process for a technology and process for a technology and process
[0118] The advantageous features of the present invention are described in conjunction with the accompanying drawings and limited specific implementation methods, but the present invention is not limited thereto and can generally be modified or expanded in various ways in the relevant technical field with conditions and scope similar to those of the above-mentioned claims.
[0119] In order to verify the system and method for producing amino acids by separating whole blood into plasma and blood cells provided in the specific embodiment of the present invention, the following experiment is described in detail. The following experiment is only an example of the present invention and is not limited thereto.
[0120] 1. Experimental Preparation
[0121] Sample 1: Whole blood from cattle slaughter (2°C refrigerated)
[0122] Sample 2: Separate the plasma and blood cells from sample 1 using a continuous centrifuge (10,000 rpm, 100 l / h) (refrigerated at 2°C)
[0123] (When using a small amount, the blood cells can be separated into layers by utilizing the blood cell sedimentation effect due to gravity.)
[0124] pH calibration solution: NaOH 5% aqueous solution (pH 14.00), citric acid (C6H8O7) 10% aqueous solution (pH 1.68)
[0125] Hypotonic solution: distilled water (DW)
[0126] Hydrolase: Six commercial enzymes are mixed according to the characteristics of the substrate such as pH and temperature for optimal activity:
[0127] 3 kinds of proteolytic enzymes (Bromeline 20% v / v + Savinase 30% v / v + Flavourzyme 40% v / v) + 1 kind of lipolytic enzyme (Lipex 6% v / v) + 1 kind of polysaccharide degrading enzyme (Glucoamylase 2% v / v) + 1 kind of fibrinolytic enzyme (Carezyme 2% v / v)
[0128] Disinfectant: Mix 2 types - Potassium sorbate 80% w / w + NaHCO3 20% w / w
[0129] The free amino acid analysis of the experimental results was performed using an amino acid analyzer (Amino Acid Analyzer L-8900).
[0130] Specifications of Amino Acid Analyzer (L-8900)
[0131] 1. Performance: Reaction type after protein hydrolysis analysis (ninhydrin reagent)
[0132] 2. Detection line (DL): 3pmol (S / N 2, Asp)
[0133] 3. Detector: Photometer 440,570nm
[0134] 4. Injection solvent: 20μl
[0135] 5. Sample cycle times: PH 53min, PF 148min
[0136] Experiment 1: Measurement of free amino acid content of hydrolyzate of plasma according to time period of the present invention
[0137] The results of quantitative analysis of the plasma components separated by the continuous centrifuge according to the AOAC (Association of Official Analytical Chemists) standard analysis method are shown in Table 2.
[0138]
Table 2
[0139] category sp.gr ph Moisture Crude Protein Coarse ash plasma 1.02 7.21 <![CDATA[90.59±1.02% 1) ]]> <![CDATA[7.56±0.79% 1) ]]> <![CDATA[1.5±0.27% 1) ]]>
[0140] *1 Mean ± SD
[0141] *Quantitative analysis method: moisture (110℃ normal pressure heating and drying method), crude protein (Kjeldahl method), crude ash (600℃ direct ash method)
[0142] First, in order to hydrolyze plasma, the pH value was corrected to the most suitable pH value of 5.50 for the activity of various hydrolases using a 10% aqueous solution of citric acid (C6H8O7) (pH 1.68), the temperature was 52°C, and the stirring speed was maintained at 120rpm. Under the above conditions, the amount of hydrolase injected was set to different 0.3% v / v, 0.5% v / v, and 0.7% v / v, respectively. After 60 minutes, the free amino acid content of the hydrolyzate was analyzed every 30 minutes. The sample for free amino acid analysis was diluted to the same concentration as the free amino acid standard sample to maintain consistency and accuracy. The analysis results of the hydrolyzate at different time periods for different hydrolase injection amounts of plasma in Table 2 are shown in Table 3.
[0143]
Table 3
[0144]
[0145] As shown in Table 3, from the results of free amino acid analysis, there is almost no difference in hydrolysis ability between 0.5% v / v and 0.7% v / v hydrolases at different time periods. After the amino acid conversion rate reaches 96-98% at the time point of 120 minutes, there is no significant change after a period of time. After the amino acid conversion rate of 0.3% v / v hydrolases reaches 89% at the time point of 150 minutes, the conversion rate does not increase after a long time. It can be seen that from the perspective of economy and efficiency, the most suitable hydrolase injection amount is 0.5% v / v. In addition, plasma does not need to destroy the cell membrane like blood cells. When the water content reaches 91% and other conditions for creating the most suitable hydrolase activity, the amino acid conversion rate reaches 96-98% in the shortest 120 minutes.
[0146] Experiment 2: Free amino acid content of blood cell hydrolysate at different time periods
[0147] Table 4 shows the results of quantitative analysis of the components of blood cells separated by the continuous centrifuge according to the AOAC (Association of Official Analytical Chemists) standard analysis method.
[0148]
Table 4
[0149] category sp.gr ph Moisture Crude Protein Crude fat Blood cells 1.09 7.21 <![CDATA[68.84±0.76% 1) ]]> <![CDATA[29.23±1.41% 1) ]]> <![CDATA[1.24±0.58% 1) ]]>
[0150] *1 Mean ± standard deviation
[0151] *Quantitative analysis method: moisture (110℃ normal pressure heating and drying method), crude protein (Kjeldahi method), crude fat (Soxhlet extraction method)
[0152] First, in order to destroy the blood cell membrane that hinders the activity of hydrolytic enzymes, distilled water (DW) was selected as the hypotonic solution. Compared with the total amount of blood cells, the content of water and protein under different distilled water (DW) addition conditions is shown in Table 5.
[0153]
Table 5
[0154]
[0155] According to the results in Table 5, for the blood cells without adding distilled water (DW) and the total amount of blood cells compared with the three types of distilled water (DW) added (80% v / v, 150% v / v, 231% v / v), a total of four types were corrected to pH 5.50, which is most suitable for the activity of different types of hydrolases, with a 10% aqueous solution of citric acid (C6H8O7) (pH 1.68), and the stirring speed was maintained at 120 rpm under the condition of 52°C. Under the above conditions, the injection amount of the hydrolase was selected as 0.5% v / v as in Experiment 1. After the injection of the hydrolase, the free amino acid content of the hydrolyzate was analyzed at 120min, 150min, and 180min. In addition, the sample for free amino acid analysis was diluted to the same concentration as the free amino acid standard sample to maintain consistency and accuracy. The analysis results of blood cell hydrolyzates at different time periods after the injection of four types of hydrolases in Table 5 are shown in Table 6.
[0156]
Table 6
[0157]
[0158] As can be seen in Table 6, from the results of free amino acid analysis, when distilled water (DW) was not added, the amino acid conversion rate of blood cells was 25% after 120 minutes and 28% after 180 minutes, which shows that no further hydrolysis was carried out. This shows that in the state where the blood cells were not hemolyzed, the cell membrane hindered the activity of the hydrolase. The amino acid conversion rate of blood cells added with 80% v / v distilled water (DW) reached 65% at 120 minutes and 72% at 180 minutes, and no further hydrolysis was carried out, indicating that the blood cells were not completely destroyed. The amino acid conversion rate of blood cells added with 150% v / v and 231% v / v distilled water (DW) was as high as 96-97% at 120 minutes, indicating that the blood cells were completely destroyed. From the above results, considering the amino acid conversion rate of blood cells, the distilled water (DW) that is suitable for addition is about 150% v / v. Of course, in order to quickly destroy blood cells, when distilled water (DW) is added at 150% v / v or more, although the amino acid conversion rate can be quickly increased, the concentration will be reduced, which is not conducive to economic efficiency.
[0159] Experiment 3: Preparation of plant extracts with antibacterial activity
[0160] In order to prevent spoilage and the like, the plasma amino acids and blood cell amino acids produced in the present invention are sterilized separately. At this time, after the sterilization, when 0.01-2% w / w of the pumpkin leaf hot water extract, rambutan ethanol extract, or a mixture of the two antibacterial extracts as shown below is added, the shelf life of the amino acids can be extended.
[0161] (1) Production of Pumpkin Leaf Hot Water Extract
[0162] 500 g of chopped pumpkin leaves and 1.5 liters of water were poured into an extraction container and boiled until the volume was reduced to 1 liter. The extract was then separated by filtration and concentrated again to 1 / 2 of the volume to produce a pumpkin leaf hot water extract.
[0163] (2) Production of rambutan ethanol extract
[0164] 1 kg of rambutan peel was chopped and mixed with 10 liters of 50-70 volume % ethanol, and stirred at 60-80° C. and 300 rpm for 3 hours using a stirrer to prepare an extraction solution.
[0165] Next, the extraction solution was filtered once using non-woven filter paper and then filtered using diatomaceous earth to prevent precipitation.
[0166] The recovered secondary filtrate was concentrated under reduced pressure using a concentrator at 60° C. to obtain the rambutan peel ethanol extract.
[0167] (3) Confirming the safety of pumpkin leaf hot water extract and rambutan ethanol extract
[0168] The experimental animals were 4-week-old Sprague-Dawley male mice (CentralLab animal, Seoul, Korea) placed in a breeding room with a set environment (temperature 20°C, humidity 55%, 12-hour dark / light cycle) and fed with granular solid feed (Jeil animal feed Co., Daejeon, Korea) for two weeks. 6-week-old mice with an average body weight of about 200 g were selected to test the toxicity of the above-mentioned pumpkin leaf hot water extract and rambutan ethanol extract.
[0169] Specifically, five 4-week-old mice were fed 30 ml of pumpkin leaf hot water extract and rambutan ethanol extract and granular solid feed (Jeil animal feed Co., Daejeon, Korea) every day for 4 weeks to evaluate toxicity.
[0170] According to the above toxicity assessment results, none of the mice participating in the experiment died, and all 10 mice remained in good health within four weeks.
[0171] (4) Experiment: Measurement of antibacterial activity
[0172] The antimicrobial activities of hot water extracts of pumpkin leaves and ethanol extracts of rambutan were evaluated by the following method. Representative food poisoning bacteria (Bacillus cereus, Bacillus subtilis, Campylobacter jejuni, Escherichia coli, Escherichia coli O-157, Listeria monocytogenes, Pseudomonas aeruginosa, Staphylococcus aureus, Salmonella enteritidis, Salmonella thypimurium, Vibrio parahaemolyticus, Yersinia enterocolitica) were used.
[0173] The above bacteria were inoculated with 50μl of culture in 10ml of sterilized TSB medium and subcultured at 30℃ for 24±1 hours. The culture concentration maintained Abs 0.6±0.1 at the absorption wavelength of 655nm on the microplate reader. The subcultured experimental bacteria were diluted to 10-3 times with sterile distilled water and the disc diffusion method was implemented. In other words, a sterile cotton swab was used to pick it up, and it was evenly spread on a 4mm thick plate medium, and a sterile 8mm (1mm thick) filter paper was placed on it, and 50μl of the above pumpkin leaf hot water extract, rambutan ethanol extract and their mixture (weight ratio = 1:1) were injected respectively. After full absorption for about 20 minutes, the growth ring was confirmed after culturing at 30℃ for 24±1 hours.
[0174] The size of the transparent band including the filter paper was measured, and the antibacterial activity results are shown in Table 7.
[0175]
Table 7
[0176]
[0177] (strain) a: ATCC: American Type Culture Collection, KCTC: Korea Biotechnology Research Institute Bioresource Center; KCCM: Korea Cultivar Culture Association
[0178] b: Size of the transparent zone (diameter mm)
[0179] As shown in Table 7, both the pumpkin leaf hot water extract and the rambutan peel ethanol extract showed excellent antibacterial activity against all bacteria. It was also confirmed that the mixture thereof showed a synergistic effect.
[0180] The above describes the specific embodiments of the present invention, but the present invention is not limited thereto, and can also be widely used in the field of recycling whole blood such as processed food, livestock feed, and nutritional supplements for crops. In addition, various different variations can be made within the scope of the claims, detailed description, and drawings of the present invention, which of course also belong to the scope of the present invention.
Claims
1. A method for producing amino acids using an amino acid production system, characterized in that: The amino acid production system comprises: A centrifuge to centrifuge the whole blood produced during cattle slaughter; A plasma hydrolysis tank receives the plasma separated from the centrifugal separator and includes a first indirect heater and a first quantitative injection device to hydrolyze the plasma into plasma amino acids; A blood cell hydrolysis tank receives the blood cells separated from the centrifuge and includes a second indirect heater and a second quantitative injection device to hydrolyze the blood cells into blood cell amino acids; The first filter filters the hydrolyzed plasma amino acids in the plasma hydrolysis tank; A second filter is used to filter the hydrolyzed blood cell amino acids in the blood cell hydrolysis tank; and The plasma amino acid storage tank and the blood cell amino acid storage tank respectively receive the plasma amino acids and blood cell amino acids filtered in the first filter and the second filter. The plasma amino acid storage tank includes a first disinfectant injection device, and the blood cell amino acid storage tank includes a second disinfectant injection device. Wherein, the method comprises: a) centrifuging the whole blood produced during cattle slaughter to separate it into plasma and blood cells; b) transporting the separated plasma to a plasma hydrolysis tank, adjusting the plasma temperature to 52° C., adjusting the pH value to 5.50, setting the stirring speed to 120 rpm, injecting 0.5% v / v plasma hydrolase to hydrolyze the high molecular organic plasma into low molecular organic plasma amino acids, wherein the plasma hydrolase comprises 20% v / v Bromeline, 30% v / v Savinase, 40% v / v Flavourzyme, 6% v / v Lipex, 2% v / v Glucoamylase and 2% v / v Carezyme; c) transporting the separated blood cells to a blood cell hydrolysis tank, injecting 150% v / v distilled water based on 100% v / v of the blood cells as a hypotonic solution to destroy the blood cell membrane, setting the stirring speed to 120 rpm, and adjusting the temperature of the blood cells with destroyed cell membranes to 52° C., and after the pH value is corrected to 5.50, injecting 0.5% v / v blood cell hydrolase to hydrolyze the high molecular organic blood cells into low molecular organic blood cell amino acids, wherein the blood cell hydrolase includes 20% v / v Bromeline, 30% v / v Savinase, 40% v / v Flavourzyme, 6% v / v Lipex, 2% v / v Glucoamylase and 2% v / v Carezyme; d) filtering the hydrolyzed plasma amino acids and blood cell amino acids respectively to remove foreign matter; e) transporting the filtered plasma amino acids and blood cell amino acids to a plasma amino acid storage tank and a blood cell amino acid storage tank respectively; and f) injecting disinfectant into the plasma amino acid storage tank and the blood cell amino acid storage tank respectively, The disinfectant comprises pumpkin leaf hot water extract and rambutan ethanol extract mixed in a weight ratio of 3:7 to 7:
3.
2. The method according to claim 1, characterized in that: The centrifuge and the plasma hydrolysis tank, the centrifuge and the blood cell hydrolysis tank, the plasma hydrolysis tank and the first filter, the blood cell hydrolysis tank and the second filter, the first filter and the plasma amino acid storage tank, and the second filter and the blood cell amino acid storage tank are connected respectively through conveying pipes.
3. The method according to claim 2, characterized in that The conveying pipe between the centrifuge and the plasma hydrolysis tank, the conveying pipe between the centrifuge and the blood cell hydrolysis tank, the conveying pipe between the plasma hydrolysis tank and the first filter, and the conveying pipe between the blood cell hydrolysis tank and the second filter are respectively equipped with conveying pumps.
4. The method according to claim 3, characterized in that The plasma hydrolysis tank, the plasma amino acid storage tank, the blood cell hydrolysis tank, and the blood cell amino acid storage tank further include circulation pipes for reprocessing the products discharged from the respective tanks.
5. The method according to claim 4, characterized in that One end of each circulation pipe is connected to a delivery pipe for delivering the product from each tank to the next stage, and the other end is connected to each tank. Wherein, the connection part between the above-mentioned delivery pipe and the circulation pipe is equipped with: The valve connects the delivery pipeline with the circulation pipe and cuts off or blocks the connection between the delivery pipeline and the circulation pipe.
6. The method according to claim 1, characterized in that The blood cell hydrolysis tank destroys the blood cell membrane by hemolysis based on the osmotic pressure principle using the hypotonic solution supplied from the hypotonic solution supply tank.
7. The method according to claim 6, characterized in that Also includes: The mixed amino acid storage tank mixes and stores the plasma amino acids and blood cell amino acids delivered from the plasma amino acid storage tank and the blood cell amino acid storage tank.
8. The method according to claim 7, characterized in that The first disinfectant injection device and the second disinfectant injection device further add one or more food additives selected from potassium sorbate, sodium benzoate and silicic acid as disinfectants.
9. The method according to claim 8, characterized in that The first disinfectant injection device and the second disinfectant injection device further add one or more selected from sodium chloride, sodium bicarbonate and wood acetic acid as disinfectants.
